Fri, May 27, 2022
Thu, May 26, 2022
Wed, May 25, 2022
Tue, May 24, 2022
Mon, May 23, 2022
Sat, May 21, 2022
Fri, May 20, 2022

Madhu Kumar Maintained (ARCT) at Strong Sell with Decreased Target to $8 on, May 24th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-8-on-may-24th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Madhu Kumar of Goldman Sachs, Maintained "Arcturus Therapeutics Holdings Inc." (ARCT) at Strong Sell with Decreased Target from $14 to $8 on, May 24th, 2022.

Madhu has made no other calls on ARCT in the last 4 months.



There are 6 other peers that have a rating on ARCT. Out of the 6 peers that are also analyzing ARCT, 3 agree with Madhu's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Joel Beatty of "Baird" Upgraded from Sell to Hold and Decreased Target to $18 on, Wednesday, May 11th, 2022
  • Ed Arce of "HC Wainwright & Co." Maintained at Hold with Decreased Target to $19 on, Tuesday, May 10th, 2022
  • Steven Seedhouse of "Raymond James" Upgraded from Sell to Hold on, Monday, January 31st, 2022


These are the ratings of the 3 analyists that currently disagree with Madhu


  • Gena Wang of "Barclays" Maintained at Sell with Decreased Target to $17 on, Tuesday, May 10th, 2022
  • John Abbott of "Wells Fargo" Maintained at Buy with Decreased Target to $105 on, Friday, March 25th, 2022
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $86 on, Tuesday, March 15th, 2022

Publication Contributing Sources